Leah Elizabeth Appel

USPTO Granted Patents = 16 (Patent Applications = 7)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 227(Granted Patents)

Company Filing History:

Acer Therapeutics Inc.

Years Active: 2004-2022

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11433041 - Palatable compositions including sodium phenylbutyrate and uses thereof (2022-09-06),

2. 11202767 - Methods of treating urea cycle disorders and maple syrup urine disease (2021-12-21),

3. 11154521 - Palatable compositions including sodium phenylbutyrate and uses thereof (2021-10-26),

4. 11116728 - Multiparticulates of spray-coated drug and polymer on a meltable core (2021-09-14),

5. 10357462 - Multiparticulates of spray-coated drug and polymer on a meltable core (2019-07-23),

6. 9445998 - Pharmaceutical dosage forms comprising a low-solubility drug and a polymer (2016-09-20),

7. 9211261 - Immediate release dosage forms containing solid drug dispersions (2015-12-15),

8. 9028870 - Hydrogel-driven drug dosage form (2015-05-12),

9. 8236349 - Taste-masked drugs in rupturing multiparticulates (2012-08-07),

10. 7951403 - Method of making pharmaceutical multiparticulates (2011-05-31),

11. 7887844 - Multiparticulate crystalline drug compositions having controlled release profiles (2011-02-15),

12. 7736672 - Multiparticulate compositions with improved stability (2010-06-15),

13. 7625507 - Extrusion process for forming chemically stable drug multiparticulates (2009-12-01),

14. 7550158 - Controlled release by extrusion of solid amorphous dispersions of drugs (2009-06-23),

15. 6984403 - Azithromycin dosage forms with reduced side effects (2006-01-10),

Title: The Innovative Journey of Leah Elizabeth Appel

Introduction

Leah Elizabeth Appel is a remarkable inventor based in Bend, Oregon, who has made significant contributions to the field of pharmaceuticals and medicine. With a total of 16 patents to her name, Leah has focused her efforts on developing advanced therapies for various metabolic and neurodegenerative disorders. Her inventive spirit and dedication to improving patient outcomes have positioned her as a leading figure in her area of expertise.

Latest Patents

One of Leah's most recent patents is focused on palatable pharmaceutical compositions that include sodium phenylbutyrate. This innovative invention not only presents a new way to treat inborn errors of metabolism, such as Maple Syrup Urine Disease or Urea Cycle Disorders, but also addresses neurodegenerative diseases, including Parkinson's disease, spinal muscular atrophy, dystonia, and inclusion-body myositis. Additionally, she has developed methods specifically aimed at treating urea cycle disorders and Maple Syrup Urine Disease, showcasing her commitment to addressing complex medical challenges.

Career Highlights

Leah has had an illustrious career, marked by her affiliation with renowned companies such as Pfizer Corporation and Bend Research, Inc. These experiences have enabled her to refine her skills in pharmaceutical development and innovation, while also amplifying her impact on the healthcare sector. Her contributions have been pivotal in advancing treatment options for patients suffering from various metabolic diseases.

Collaborations

Throughout her career, Leah has collaborated with talented professionals, including colleagues like Dwayne Thomas Friesen and Joshua R Shockey. These partnerships have fostered a collaborative environment that has led to the successful development of patents and innovative therapies.

Conclusion

Leah Elizabeth Appel stands out as a pioneering inventor who continues to push the boundaries of medical innovation. Through her groundbreaking patents and unwavering dedication to improving patient care, Leah is making a lasting impact on the field of pharmaceuticals. Her work not only highlights the importance of innovation in medicine but also serves as an inspiration for future inventors aiming to make a difference.

This text is generated by artificial intelligence and may not be accurate.